OASIS 4 — Oral Semaglutide 25mg

Source: New England Journal of Medicine (2025).

Key finding: 13.6% weight loss with oral semaglutide.

Part of GLP1Score's 20-study clinical evidence library — the peer-reviewed research powering our GLP-1 eligibility scoring engine.

Related Reading

Semaglutide in India — Complete Guide
Semaglutide Drug Monograph (dosing, contraindications)
Who Qualifies for Semaglutide in India
ADA Standards of Care in Diabetes — 2026
Endocrine Society of India Clinical Practice Guidelines for Obesity Management
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)

Take the Free Eligibility Assessment → · Compare All 18+ Brands